简体中文 | 繁體中文 | English

Press Releases

2025-06-05 11:26 LambdaTest Integrates with Assembla to Streamline Bug Tracking for Development Teams
2025-06-05 11:21 Datasite Acquires Leading Private Market Intelligence Company Grata with $500 Million Investment Commitment
2025-06-05 11:17 “Account Takeovers Increasingly Used to Manipulate Markets” - Solidus Labs Report Urges Unified Cyber-Compliance Response
2025-06-05 11:08 CB Insights Announces Collaboration with Snowflake to Make Market Intelligence Accessible to AI and Agents in Real Time
2025-06-05 11:03 I Squared Capital Acquires a Leading Cold Storage Operator in the Philippines
2025-06-05 10:43 Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania
2025-06-05 10:37 Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
2025-06-05 10:31 The Future of AI in the AEC Industry Unveiled at BST Global’s 2025 AI Summit
2025-06-04 13:11 ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis
2025-06-04 13:07 Andersen Consulting Announces Collaboration with Bretteville Consulting
2025-06-04 13:05 BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025
2025-06-04 11:27 Venture Global Launches Site Work at CP2 LNG Following Federal Approval
2025-06-04 11:23 MAG Group Holding Launches Riviera Heights, First Phase of Jordan’s Marsa Zayed Red Sea Beachfront Community
2025-06-04 11:20 Klarna and Visa Launch Pilot of New Debit Card with Increased Flexibility at Money 2020 Europe
2025-06-04 11:17 Visa Appoints Andrew Torre as President of Value-Added Services
2025-06-04 10:47 Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors
2025-06-04 10:44 HCLTech and UiPath Partner to Accelerate Agentic Automation for Global Enterprises
2025-06-04 10:41 European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
2025-06-04 10:37 Automotive Industry Shifts Gears As Talent and Technology Take Center Stage
2025-06-04 10:32 OpenGMSL™ Association Announces Formation to Revolutionize the Future of In-Vehicle Connectivity

Business Wire Weibo

Industries

Latest Releases